The Brain Blend - Dihexa (10mg)/ Tesofensine (250mcg)/ BPC-157 (125mcg) (60 Tablets)

The Brain Blend: Neuro-Regenerative Ecosystem

Composition: Dihexa (10mg) / Tesofensine (250mcg) / BPC-157 (125mcg) Format: Oral Formulation (Research Grade) Class: Multi-Modal Nootropic & Synaptogenic Stack Target: HGF/c-Met Signaling, Triple Monoamine Reuptake, VEGFR2 Angiogenesis

Product Overview

The Brain Blend is a high-level research formulation designed to address the structural, functional, and systemic layers of cognitive health. By integrating three distinct pharmacological classes, this stack moves beyond simple neurotransmitter temporary boosting to focus on the physical reconstruction of the brain's neural networks.

This blend targets the "Architectural Triad" of the central nervous system:

1. Structural: Rebuilding physical connections (Dihexa).

2. Functional: Optimizing signaling and neurotransmission (Tesofensine).

3. Environmental: Ensuring vascular integrity and inflammatory stability (BPC-157).

Mechanism of Action: The Highway and Traffic Paradigm

The Brain Blend utilizes a "highway and traffic" model for neural optimization:

• Dihexa (The Road Builder): A picomolar-potency HGF mimetic that is approximately seven million times more powerful than BDNF. It drives synaptogenesis (the creation of new synapses) and dendritic arborization by activating the c-Met receptor. This effectively "rebuilds the highways" of the brain.

• Tesofensine (The Traffic Controller): A triple monoamine reuptake inhibitor (SNDRI) that elevates serotonin, dopamine, and norepinephrine. It sharpens focus, enhances satiety, and increases metabolic expenditure, ensuring that the "traffic" on the newly built neural highways is optimized for speed and efficiency.

• BPC-157 (The Environmental Stabilizer): A gastric-derived pentadecapeptide that promotes angiogenesis via the VEGFR2 pathway. It ensures a robust blood supply to support new neural structures while balancing the GABA and Dopamine systems to prevent overstimulation and neuroinflammation.

Key Research Applications

1. Synaptic Density & Cognitive Repair Investigated for its ability to reverse scopolamine-induced amnesia and age-related cognitive decline. Research shows Dihexa can increase hippocampal spine density by up to 3-fold, creating a physical foundation for improved memory.

2. Metabolic Resilience & Satiety Tesofensine is studied for its dual-action as an appetite suppressant and metabolic stimulator. In clinical research, it has achieved significantly higher weight loss percentages than standard agents by modulating the lateral hypothalamus.

3. Neuroprotection & Stroke Recovery The inclusion of BPC-157 makes this blend a candidate for research into brain lesion repair. Studies indicate BPC-157 can resolve hippocampal damage following ischemic insult and normalize neurotransmitter imbalances during pharmacological stress.

Storage & Handling

• Physical State: Specialized oral research formulation.

• Storage: Store in a cool, dry place away from direct sunlight.

• Long-Term Storage: Store at -20°C (Freezer) to maintain maximum stability of the HGF mimetics and SNDRI components.

• Stability: Dihexa is exceptionally stable; however, Tesofensine requires protection from moisture to prevent degradation.

Disclaimer

FOR RESEARCH USE ONLY. This product is a chemical compound intended strictly for laboratory research and development. It is not approved by the FDA for clinical use, diagnostics, or therapeutic procedures in humans or animals. The physiological and toxicological properties of this chemical have not been fully investigated.